A new study reveals stopping GLP-1 weight loss drugs leads to rapid weight regain, nearly four times faster than quitting ...

Researchers say they have finally discovered the pathway by which obesity causes runaway inflammation that can lead to a host ...

Across all income levels, bariatric surgery resulted in better diabetes control than GLP-1s or similar medications, a study ...

Kanagawa University of Human Services-led researchers found short-term BMI reductions after an eight-to-12-week ...

Viking Therapeutics completes enrollment in a phase I maintenance study of VK2735, testing flexible oral and injectable ...

Weight loss drugs like Ozempic and Wegovy have had a meteoric rise in recent years, but how fast does the weight return after ...

The retrospective study could not determine whether some patients were more likely than others to keep off the weight.

The performance of asthma severity scores, in terms of reliability and responsiveness, differs between children with obesity ...

Abdominal fat is not a uniform tissue. A new study from Karolinska Institutet, Steno Diabetes Center Copenhagen, and ...

Once-weekly semaglutide significantly reduces hospital admissions and total hospital stay in patients with CVD and obesity.

A team led by UT Southwestern Medical Center researchers has uncovered a molecular pathway that links obesity to widespread ...

Many patients taking obesity and diabetes drugs like Ozempic and Wegovy have found its benefits go beyond weight loss.